Citation: | Shen Guojie, Tu Zhenhua. Interpretation of Guide to the Quality and Safety of Organs for Transplantation (6th edition): biosafety early warning[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 98-103. doi: 10.3969/j.issn.1674-7445.2020.01.016 |
[1] |
BRETT KE, RITCHIE LJ, ERTEL E, et al. Quality metrics in solid organ transplantation: a systematic review[J]. Transplantation, 2018, 102(7):e308-e330. DOI: 10.1097/TP.0000000000002149.
|
[2] |
SALMELA K. Quality and safety of organ transplantation[J]. Ann Transplant, 2004, 9(1):51-52.
|
[3] |
GREEN M, COVINGTON S, TARANTO S, et al. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee[J]. Transplantation, 2015, 99(2):282-287. DOI: 10.1097/TP.0000000000000584.
|
[4] |
MARAZUELA R, GARRIDO G, MATESANZ R. European Union and Spanish regulations on quality and safety of tissues and cells: overview and biovigilance[J]. Transplant Proc, 2009, 41(6):2044-2046. DOI: 10.1016/j.transproceed.2009.06.033.
|
[5] |
European Committee (Partial Agreement) on Organ Transplantation (CD-P-TO) EDQM.移植器官质量与安全指南(原书第6版)[M].张雷, 译.北京: 科学出版社, 2019.
|
[6] |
Directive 2010/45/EU of the European parliament and of the council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation [EB/OL]. (2016-01-30). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:207:0014:0029:EN:PDF.
|
[7] |
ISON MG, HAGER J, BLUMBERG E, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee[J]. Am J Transplant, 2009, 9(8): 1929-1935. DOI: 10.1111/j.1600-6143.2009.02700.x.
|
[8] |
GARZONI C, ISON MG. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation[J]. Transplantation, 2011, 92(12):1297-1300. DOI: 10.1097/TP.0b013e318236cd02.
|
[9] |
MILLER R, COVINGTON S, TARANTO S, et al. Communication gaps associated with donor-derived infections[J]. Am J Transplant, 2015, 15(1):259-264. DOI: 10.1111/ajt.12978.
|
[10] |
GKIOKA V, TSIRIGOTIS P, SARRIS M, et al. Biovigilance for the quality and safety of medical products of human origin[J]. J Clin Med Res, 2018, 10(12):857-867. DOI: 10.14740/jocmr3549w.
|
[11] |
SNYDER JJ, SALKOWSKI N, KIM SJ, et al. Developing statistical models to assess Transplant Outcomes Using National Registries: the process in the United States[J]. Transplantation, 2016, 100(2): 288-294. DOI: 10.1097/TP.0000000000000891.
|
[12] |
KAYE S, BADDON A, JONES M, et al. A UK scheme for reporting serious adverse events and reactions associated with ocular tissue transplantation[J]. Cell Tissue Bank, 2010, 11(1):39-46. DOI: 10.1007/s10561-009-9139-y.
|
[13] |
Notify Library[EB/OL]. (2016-01-30). http://www.notifylibrary.org.
|
[14] |
GALLAGHER TH, WATERMAN AD, EBERS AG, et al. Patients' and physicians' attitudes regarding the disclosure of medical errors[J]. JAMA, 2003, 289(8):1001-1007. doi: 10.1001/jama.289.8.1001
|
[15] |
ISON MG, NALESNIK MA. An update on donor-derived disease transmission in organ transplantation[J]. Am J Transplant, 2011, 11(6):1123-1130. DOI: 10.1111/j.1600-6143.2011.03493.x.
|
[16] |
ISON MG, HOLL JL, LADNER D. Preventable errors in organ transplantation: an emerging patient safety issue?[J]. Am J Transplant, 2012, 12(9):2307-2312. DOI: 10.1111/j.1600-6143.2012.04139.x.
|
[17] |
MATHUR AK, STEMPER-BARTKUS C, ENGHOLDT K, et al. Identifying patterns of adverse events of solid organ transplantation through departmental case reviews[J]. Mayo Clin Proc Innov Qual Outcomes, 2019, 3(3):335-343. DOI: 10.1016/j.mayocpiqo.2019.04.007.
|
[18] |
ECHENIQUE IA, ISON MG. Update on donor-derived infections in liver transplantation[J]. Liver Transpl, 2013, 19(6):575-585. DOI: 10.1002/lt.23640.
|
[19] |
VAN ASSCHE K, STERCKX S, LENNERLING A, et al. The relevance of directive 2010/53/EU for living organ donation practice: an ELPAT view[J]. Transplantation, 2015, 99(10):2215-2222. DOI: 10.1097/TP.0000000000000670.
|
[20] |
LUMBRERAS C, SANZ F, GONZÁLEZ A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients[J]. Clin Infect Dis, 2001, 33(5):722-726. doi: 10.1086/322599
|
[21] |
MARTINIÈRE K, LUCAS S, ZORZI P. Events and adverse reactions in biovigilance: descriptive analysis of French national data following a four-year practical experience[J]. Transfus Clin Biol, 2008, 15(4):179-189. DOI: 10.1016/j.tracli.2008.04.008.
|
[22] |
CZERWIŃSKI J, ANTOSZKIEWICZ K, GRYGIEL K, et al. National Transplants Registry in Poland: early and long-term results of organ transplantations in the years 1998 to 2014[J]. Transplant Proc, 2016, 48(5):1407-1410. DOI: 10.1016/j.transproceed.2016.01.086.
|
[23] |
CAMERON AM, SULLIVAN BE. Regulatory oversight in transplantation: there and back again[J]. JAMA Surg, 2013, 148(11):997-998. DOI: 10.1001/jamasurg.2013.2762.
|
[24] |
SoHO V & S Guidance for competent authorities: communication and investigation of serious adverse events and reactions associated with human tissues and cells[EB/OL]. (2016-01-30). http://www.notifylibrary.org/sites/default/files/SOHO%20V%26S%20Communication%20and%20Investigation%20Guidance.pdf.
|
[25] |
LEN O, GARZONI C, LUMBRERAS C, et al. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections[J]. Clin Microbiol Infect, 2014, 20(Suppl 7):10-18. DOI: 10.1111/1469-0691.12557.
|
[26] |
STRONG DM. Tissue banking, biovigilance and the notify library[J]. Cell Tissue Bank, 2018, 19(2):187-195. DOI: 10.1007/s10561-017-9639-0.
|
[27] |
FEHILY D. Sharing vigilance experience and knowledge globally - a preliminary overview of the Notify Library[J]. Cells Tissues Organs, 2013, 16:117-125.
|
[28] |
STEWART DE, TLUSTY SM, TAYLOR KH, et al. Trends and patterns in reporting of patient safety situations in transplantation[J]. Am J Transplant, 2015, 15(12):3123-3133. DOI: 10.1111/ajt.13528.
|